BACKGROUND: Arterial hypertension and chronic obstructive pulmonary disease have a deleterious effect on the structure of the heart, leading to the development of atrial fibrillation, which remains the leading cause of cerebral stroke and premature death [1]. Consequently, the early identification of atrial fibrillation risk factors in patients with arterial hypertension and chronic obstructive pulmonary disease is of paramount importance for the prevention of such conditions. This is why predictive cardiology employs machine learning methods, which are demonstrably superior to classical statistical methods of prediction [2–4]. AIM: The study aimed to develop a prognostic model of atrial fibrillation in comorbid patients with arterial hypertension and chronic obstructive pulmonary disease based on multilayer perceptron. MATERIALS AND METHODS: The study included 419 patients treated at the University Clinical Hospital No. 4 of the I.M. Sechenov First Moscow State Medical University. Group 1 consisted of 91 (21.7%) patients with a verified diagnosis of atrial fibrillation, while Group 2 comprised 328 (78.3%) patients without atrial fibrillation. The random forest machine learning algorithm was used to identify predictors, which were then utilized to develop a neural network of the multilayer perceptron type. This consisted of two layers: an input layer of 12 neurons with the ReLU activation function and an output layer that receives input data from the previous layer and transmits them to one output with the sigmoid activation function. The threshold value, sensitivity, specificity, and diagnostic efficiency of the obtained model were determined using receiver operating characteristic analysis with the calculation of the area under the curve (AUC). RESULTS: By the first stage of prognostic model development, the most significant predictors of atrial fibrillation development were selected by the random forest machine learning algorithm. The model was developed using three variables: C-reactive protein concentration (odds ratio, OR 1.04; 95% confidence interval, CI 1.015–1.067; p=0.002), erythrocyte sedimentation rate (OR 1.04; 95% CI 1.019–1.069; p=0.002), and creatinine concentration (OR 1.03; 95% CI 1.011–1.042; p 0.001). These variables were used to train a multilayer perceptron model on a test sample for 500 epochs. Following training, the developed model exhibited a sensitivity of 85%, a specificity of 80%, and a diagnostic efficiency of 79.6%. AUC amounted to 0.900. CONCLUSIONS: The study resulted in the development of a prognostic model based on the application of machine learning methods, which exhibited favorable metrics. This model may be considered a valuable tool for clinical practice.
Background: Arterial hypertension (HTN) is associated with accelerated vascular aging, cerebral microvascular injury, and cognitive decline. Anti-NR2/GluN2 (NR2) antibodies may be related to N-methyl-D-aspartate receptor (NMDAR)-mediated neuronal-ischemic injury, although their clinical significance in HTN requires further clarification. Objective: The aim of this study was to evaluate cross-sectional associations between arterial stiffness assessed by the cardio-ankle vascular index (CAVI), serum NR2 antibody levels, and cognitive performance assessed by the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) in patients with essential HTN and controls. Methods: This single-center study included 175 adults aged 40–70 years: 128 patients with essential HTN and 47 controls. The median age was 58 [54; 66] years in the HTN group and 55 [47; 62] years in controls (p = 0.06). Men accounted for 52 patients (40.6%) in the HTN group and 14 participants (30.0%) in the control group (p = 0.22). Arterial stiffness was assessed using CAVI. Serum NR2 antibody levels were measured by enzyme-linked immunosorbent assay. Cognitive status was evaluated using MoCA and MMSE. Between-group comparisons, correlation analysis, and exploratory classification modeling were performed. Results: Patients with HTN had higher CAVI values than controls (8.3 [7.3; 9.4] vs. 7.3 [6.9; 7.9]; p = 0.001). Cognitive impairment was more frequent in hypertensive patients by both MoCA (52.3% vs. 27.7%; p = 0.003) and MMSE (48.7% vs. 28.3%; p = 0.01). NR2 antibody levels were higher in HTN (1.6 [1.15; 2.62] vs. 1.33 [1.02; 1.84] ng/mL; p = 0.03). CAVI inversely correlated with MoCA and MMSE scores. Conclusions: CAVI was higher in patients with HTN and showed modest inverse associations with cognitive scores. NR2 antibody levels were also higher in HTN; however, their relationship with cognitive impairment should be interpreted as exploratory and hypothesis-generating. Further longitudinal studies with neuroimaging are required to determine the clinical and prognostic significance of these findings.